Evidence related to lowering or improving HbA1c/A1C in diabetes management.
Diabetes evidence, synthesized.
Organizing diabetes research into clear, evidence-based insights powered by the Evidence Intelligence™ framework.
Start with a clinical question and see what the evidence says, or explore the underlying research yourself. Every conclusion stays connected to the studies behind it.
Evidence Intelligence
No subscription required to explore the evidence.
Clinical Reference
Glycemic Control
What does the evidence say?
Structured clinical evidence organized around outcomes, interventions, assertions, and the studies behind them.
23
Evidence assertions
112
Included studies
Clinical Reference turns many studies into structured clinical evidence you can inspect.
Explore Clinical ReferenceWhat does the evidence say?
Clinical Reference
Start with an outcome or intervention and examine the evidence as a structured clinical reference—not as a list of individual studies.
- 1Choose a clinical topic
- 2Review evidence assertions
- 3Examine interventions and outcomes
- 4Inspect supporting studies
Clinical Reference
Cardiovascular Risk
5
Evidence assertions
37
Included studies
Explore the evidence by intervention, assertion, and supporting research.
Explore Clinical ReferenceClinical Reference
Glycemic Control
23
Evidence assertions
112
Included studies
Explore the evidence by intervention, assertion, and supporting research.
Explore Clinical ReferenceClinical Reference
HbA1c Reduction
41
Evidence assertions
195
Included studies
Explore the evidence by intervention, assertion, and supporting research.
Explore Clinical ReferenceExplore Diabetes Evidence Topics
Prefer to explore the research directly? Browse the evidence landscape by diabetes outcome, intervention, and topic.
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
Evidence related to improving insulin resistance, insulin sensitivity, fasting insulin, C-peptide levels, and beta-cell function in diabetes and prediabetes.
Evidence related to preventing or delaying type 2 diabetes, reducing diabetes incidence, and improving metabolic risk in people with prediabetes.
Evidence related to diabetic kidney disease, albuminuria, kidney function, nephropathy progression, end-stage renal disease, and kidney-protective diabetes treatments.
How Diabetes Evidence Connects
Every study contributes evidence linking interventions and outcomes. deDiabetes organizes those findings into connected evidence topics so you can move from broad questions to supporting research.
Build and Share Evidence Collections
Create curated evidence collections and share them with anyone using a public link—no account required to view.
Top Evidence Signals
Highest-ranked evidence pairs currently in database
- •DSMES → HbA1c
- •Hybrid closed-loop system → Time in range
Most Consistent Results
Evidence with agreement across multiple studies
- •Metformin → Glucose iAUC (OGTT)
- •Semaglutide → Adverse events incidence
Most Studied Interventions
Interventions with the broadest evidence base
- •Semaglutide
- •Vitamin D supplementation
Emerging Evidence
Promising early-stage research areas
New Evidence This Month
Recently published research
What sharing looks like
Share evidence with the people who matter
Send one organized evidence resource to your physician, dietitian, family, or research colleagues.
Weight Loss Evidence
Anyone can explore without an account.
Featured Evidence Insights
Strongest findings from our evidence intelligence analysis
GLP-1 Receptor Agonists → HbA1c
Tirzepatide → HbA1c
Tirzepatide shows strong improvement in HbA1c with consistent results (well-studied, 12 studies).
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 92
- Very Positive
- ConsistencyScore™
- 93
- consistent
Non-surgical periodontal treatment → Periodontal probing depth
Non-surgical periodontal treatment shows strong improvement in Periodontal probing depth with consistent results (well-studied, 14 studies).
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 92
- consistent
GLP-1 Receptor Agonists → Body Weight
Tirzepatide → Body weight
Tirzepatide shows strong improvement in Body weight with consistent results (well-studied, 11 studies).
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 85
- Very Positive
- ConsistencyScore™
- 96
- consistent
Usual care → HbA1c
Usual care may improve HbA1c with consistent results (well-studied, 10 studies).
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 60
- Slightly Positive
- ConsistencyScore™
- 89
- consistent
GLP-1 Receptor Agonists → HbA1c
Semaglutide → HbA1c
Semaglutide shows strong improvement in HbA1c with consistent results (well-studied, 11 studies).
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 92
- Very Positive
- ConsistencyScore™
- 93
- consistent
SRP + OHI → Periodontal probing depth
SRP + OHI shows strong improvement in Periodontal probing depth with consistent results (emerging research, 7 studies).
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Living Evidence
Always Up to Date
New studies continuously strengthen, refine, or challenge existing evidence. Follow what matters and see what's changed.
Evidence Comparison Table
Highest-ranked intervention and outcome relationships
Ranked by EvidenceScore™
| # | Intervention | Outcome | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness |
|---|---|---|---|---|---|---|---|
| 1 | DSMES | HbA1c | 87/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 8 | Weak Positive |
| 2 | Semaglutide | HbA1c | 86/100Strong | 92/100Very Positive | 93/100consistent | 11 | Strong Positive |
| 3 | Semaglutide | Body weight | 85/100Strong | 85/100Very Positive | 96/100consistent | 9 | Moderate Positive |
| 4 | Metformin | HbA1c | 85/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 11 | Strong Positive |
| 5 | Metformin | Fasting Plasma Glucose (FPG) | 84/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 7 | Moderate Positive |
| 6 | Liraglutide | Body weight | 83/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 5 | Strong Positive |
| 7 | Tirzepatide | HbA1c | 83/100Strong | 92/100Very Positive | 93/100consistent | 12 | Strong Positive |
| 8 | Tirzepatide | Body weight | 83/100Strong | 85/100Very Positive | 96/100consistent | 11 | Strong Positive |
| 9 | Vitamin D supplementation | HbA1c | 82/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 5 | Moderate Positive |
| 10 | Vitamin D supplementation | Fasting Plasma Glucose (FPG) | 79/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 3 | Neutral |
| 11 | Liraglutide | HbA1c | 79/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 3 | Moderate Positive |
| 12 | Metformin | Body weight | 79/100 | Metric not available for this evidence entity | Metric not available for this evidence entity | 3 | Weak Positive |
DSMES → HbA1c
- EvidenceScore™
- 87
- Strong
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 92
- Very Positive
- ConsistencyScore™
- 93
- consistent
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 85
- Very Positive
- ConsistencyScore™
- 96
- consistent
Metformin → HbA1c
- EvidenceScore™
- 85
- Strong
Metformin → Fasting Plasma Glucose (FPG)
- EvidenceScore™
- 84
- Strong
Liraglutide → Body weight
- EvidenceScore™
- 83
- Strong
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 92
- Very Positive
- ConsistencyScore™
- 93
- consistent
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 85
- Very Positive
- ConsistencyScore™
- 96
- consistent
Vitamin D supplementation → HbA1c
- EvidenceScore™
- 82
- Strong
Vitamin D supplementation → Fasting Plasma Glucose (FPG)
- EvidenceScore™
- 79
- Strong
Liraglutide → HbA1c
- EvidenceScore™
- 79
- Strong
Metformin → Body weight
- EvidenceScore™
- 79
- Strong
How to Read Evidence Cards
Understanding an Evidence Card
Every Evidence Card summarizes one intervention-outcome relationship using Dediabetes' Evidence Intelligence system: ImpactScore™, EvidenceScore™, ConsistencyScore™, supporting study count, and direct access to the underlying evidence.
GLP-1 receptor agonists → HbA1c
Current evidence suggests a positive impact on HbA1c with strong supporting evidence and generally consistent findings across studies.
- EvidenceScore™
- 70
- Moderate
- ImpactScore™
- 82
- Positive
- ConsistencyScore™
- 89
- Consistent
Relationship
Intervention → Outcome. The evidence relationship being summarized.
Evidence Summary
A plain-language summary of what the evidence suggests.
ImpactScore™
ImpactScore™ summarizes what impact the current evidence suggests.
EvidenceScore™
EvidenceScore™ summarizes how much confidence to place in that conclusion.
ConsistencyScore™
ConsistencyScore™ summarizes how consistently independent studies reach the same conclusion.
Supporting Studies
Number of studies contributing to this evidence relationship.
Call to Action
Open the full evidence page for supporting studies, methodology, and related evidence.
ImpactScore™, EvidenceScore™, and ConsistencyScore™ are generated by the Evidence Intelligence system and are not medical advice.
Now make it yours
Build Your Personal Evidence Workspace
Save research, organize it into collections, share curated evidence with your healthcare team, family, or colleagues, and receive updates as the evidence evolves.
Save
Save research you want to revisit.
Organize
Create collections for health goals, treatments, projects, or patients.
Share
Share curated evidence with a physician, family member, or colleague.
Stay Updated
Track evidence and see what has changed as new research is added.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
